55.20
price up icon0.25%   0.14
after-market アフターアワーズ: 55.20
loading
前日終値:
$55.06
開ける:
$55.76
24時間の取引高:
868.84K
Relative Volume:
1.49
時価総額:
$1.63B
収益:
$232.39M
当期純損益:
$-26.79M
株価収益率:
-51.09
EPS:
-1.0804
ネットキャッシュフロー:
$4.41M
1週間 パフォーマンス:
+2.47%
1か月 パフォーマンス:
-6.42%
6か月 パフォーマンス:
-14.71%
1年 パフォーマンス:
+161.86%
1日の値動き範囲:
Value
$53.71
$55.77
1週間の範囲:
Value
$53.22
$55.79
52週間の値動き範囲:
Value
$20.49
$73.30

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1065)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
104
Name
Twitter
@anaptysbio
Name
次回の収益日
2026-09-16
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

Compare ANAB vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANAB icon
ANAB
Anaptysbio Inc
55.20 1.60B 232.39M -26.79M 4.41M -1.0804
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
508.34 130.64B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
784.85 80.46B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
990.32 61.58B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
154.04 57.48B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
190.95 43.68B 742.00K -1.37B -1.07B -7.0731

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-07 再開されました UBS Buy
2025-10-13 開始されました Barclays Overweight
2025-06-04 アップグレード H.C. Wainwright Neutral → Buy
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
Sep 10, 2026

AnaptysBio earnings on deck: Jemperli lawsuit takes center stage By Investing.com - Investing.com Canada

Sep 10, 2026
pulisher
Sep 10, 2026

AnaptysBio earnings on deck: Jemperli lawsuit takes center stage - investing.com

Sep 10, 2026
pulisher
Sep 10, 2026

ANAB Q2'26 Earnings: EPS estimate is (0.47) USD - TradingView

Sep 10, 2026
pulisher
Sep 09, 2026

Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB) - Yahoo Finance UK

Sep 09, 2026
pulisher
Sep 09, 2026

Squarepoint Ops LLC Has $21.90 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 09, 2026
pulisher
Sep 09, 2026

AnaptysBio, Inc. $ANAB Shares Purchased by Hsbc Holdings PLC - MarketBeat

Sep 09, 2026
pulisher
Sep 08, 2026

U.S. Earnings Preview: After Market Close Sept. 8 - moomoo.com

Sep 08, 2026
pulisher
Sep 06, 2026

Irenic Capital Management LP Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 06, 2026
pulisher
Sep 06, 2026

Bank of New York Mellon Corp Makes New $3.81 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 06, 2026
pulisher
Sep 05, 2026

Anaptysbio Stock Price Forecast. Should You Buy ANAB? - StockInvest.us

Sep 05, 2026
pulisher
Sep 04, 2026

ANAB Q2'26 Earnings: revenue estimate is 8.89M USD - TradingView

Sep 04, 2026
pulisher
Sep 01, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Sep 01, 2026
pulisher
Sep 01, 2026

U.S. Earnings Preview: After Market Close Sept. 1 - Moomoo

Sep 01, 2026
pulisher
Aug 31, 2026

AnaptysBio stock rating maintained at Outperform by Wolfe Research - Investing.com Nigeria

Aug 31, 2026
pulisher
Aug 30, 2026

AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com Australia

Aug 30, 2026
pulisher
Aug 30, 2026

AnaptysBio earnings on deck: Can Jemperli offset revenue slide? - Investing.com

Aug 30, 2026
pulisher
Aug 29, 2026

Empowered Funds LLC Makes New $13.91 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Aug 29, 2026
pulisher
Aug 29, 2026

1,844,049 Shares in AnaptysBio, Inc. $ANAB Bought by BlackRock Inc. - marketbeat.com

Aug 29, 2026
pulisher
Aug 29, 2026

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Aug 29, 2026
pulisher
Aug 28, 2026

AnaptysBio Inc. (ANAB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026
pulisher
Aug 28, 2026

Palo Alto Investors LP Purchases Shares of 603,489 AnaptysBio, Inc. $ANAB - MarketBeat

Aug 28, 2026
pulisher
Aug 28, 2026

Hsbc Holdings PLC Purchases Shares of 216,949 AnaptysBio, Inc. $ANAB - MarketBeat

Aug 28, 2026
pulisher
Aug 27, 2026

Deutsche Bank AG Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Aug 27, 2026
pulisher
Aug 27, 2026

Connor Clark & Lunn Investment Management Ltd. Takes Position in AnaptysBio, Inc. $ANAB - MarketBeat

Aug 27, 2026
pulisher
Aug 25, 2026

ANAB Maintained by TD Cowen -- Price Target Lowered to $70 - GuruFocus

Aug 25, 2026
pulisher
Aug 25, 2026

TD Cowen lowers Anaptysbio stock price target to $70 on FDA review - Investing.com UK

Aug 25, 2026
pulisher
Aug 25, 2026

TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating - Moomoo

Aug 25, 2026
pulisher
Aug 24, 2026

AnaptysBio, Inc. (ANAB) Earnings Preview: The First Full Royalty-Model Quarter Matters More Than the Headline EPS - AlphaStreet

Aug 24, 2026
pulisher
Aug 24, 2026

TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $70 - Moomoo

Aug 24, 2026
pulisher
Aug 24, 2026

AnaptysBio (NASDAQ:ANAB) Given Buy Rating at HC Wainwright - MarketBeat

Aug 24, 2026
pulisher
Aug 21, 2026

Greenhaven Road Investment Management, L.P.'s AnaptysBio Inc(ANAB) Holding History - GuruFocus

Aug 21, 2026
pulisher
Aug 19, 2026

AnaptysBio (NASDAQ:ANAB): High Growth Momentum Aligns With a Breakout Setup - ChartMill

Aug 19, 2026
pulisher
Aug 19, 2026

U.S. Earnings Preview: After Market Close Aug. 18 - Moomoo

Aug 19, 2026
pulisher
Aug 18, 2026

US High Growth Tech Stocks To Watch In August 2026 - simplywall.st

Aug 18, 2026
pulisher
Aug 17, 2026

GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control - Yahoo Finance

Aug 17, 2026
pulisher
Aug 17, 2026

Bank of America Corp DE Boosts Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat

Aug 17, 2026
pulisher
Aug 16, 2026

AnaptysBio earnings ahead: First results as royalty company By Investing.com - Investing.com Canada

Aug 16, 2026
pulisher
Aug 16, 2026

AnaptysBio earnings ahead: First results as royalty company - Investing.com

Aug 16, 2026
pulisher
Aug 15, 2026

AnaptysBio (NASDAQ:ANAB) Shares Pass Above Fifty Day Moving AverageHere's What Happened - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

AnaptysBio (ANAB) Holds Steady at $56.09: Key Levels to WatchNew Listing Stocks - vinanet.vn

Aug 14, 2026
pulisher
Aug 14, 2026

Sirenia Capital discloses 5.0% AnaptysBio (ANAB) ownership in Schedule 13G/A - Stock Titan

Aug 14, 2026
pulisher
Aug 12, 2026

H.C. Wainwright Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $95 - Moomoo

Aug 12, 2026
pulisher
Aug 12, 2026

AnaptysBio Shareholders Back Board, Governance and Incentives - The Globe and Mail

Aug 12, 2026
pulisher
Aug 11, 2026

AnaptysBio Announces Results of 2026 Annual Stockholders Meeting Voting - Kalkine Media

Aug 11, 2026
pulisher
Aug 11, 2026

AnaptysBio (ANAB) Climbs 4.33% to $57.87 as Biotech Momentum BuildsETF NAV Deviation - vinanet.vn

Aug 11, 2026
pulisher
Aug 10, 2026

Is AnaptysBio (ANAB) Undervalued After Its Recent Share Price Swings? - Sahm

Aug 10, 2026
pulisher
Aug 08, 2026

Price-Driven Insight from (ANAB) for Rule-Based Strategy - Stock Traders Daily

Aug 08, 2026
pulisher
Aug 08, 2026

AnaptysBio (ANAB) Rallies 3.36% as Biotech Momentum Builds Toward Key ResistanceGolden Cross - dars.gov.et

Aug 08, 2026
pulisher
Aug 07, 2026

AnaptysBio (ANAB) awards CEO 53,334 performance stock units - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

AnaptysBio (NASDAQ: ANAB) awards 16,667 performance stock units to its CMO - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

AnaptysBio Inc (ANAB) Stock News Today - TradingKey

Aug 07, 2026

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$58.41
price down icon 0.88%
$120.00
price down icon 3.21%
$39.77
price down icon 0.53%
$239.56
price down icon 2.42%
ONC ONC
$350.84
price down icon 0.74%
$190.95
price down icon 3.04%
大文字化:     |  ボリューム (24 時間):